Why the study?
Does heart transplantation provide good long-term survival in a child with severe doxorubicin-induced cardiomyopathy?
Does heart transplantation provide good long-term survival in a child with severe doxorubicin-induced cardiomyopathy?
Heart transplantation can be a successful long-term treatment for severe doxorubicin-induced cardiomyopathy in pediatric patients with a history of Ewing's sarcoma, without causing tumor recurrence.
No takes yet. Share an insight, caveat, or question.
May support heart transplantation in select pediatric doxorubicin cardiomyopathy cases; leaves open broader applicability and safety confirmation.
Aricò et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: